• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Population-based analysis of esophageal large cell neuroendocrine carcinoma between 2004 and 2015.2004年至2015年间食管大细胞神经内分泌癌的基于人群的分析。
J Thorac Dis. 2019 Dec;11(12):5480-5488. doi: 10.21037/jtd.2019.11.34.
2
Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma.基于监测、流行病学和最终结果(SEER)数据库对食管神经内分泌癌和食管鳞状细胞癌的临床病理特征进行比较及生存分析,并对食管神经内分泌癌进行列线图分析。
J Gastrointest Oncol. 2023 Dec 31;14(6):2309-2323. doi: 10.21037/jgo-23-905. Epub 2023 Dec 22.
3
Clinical characteristics, prognostic factors, and survival trends in esophageal neuroendocrine carcinomas: A population-based study.食管神经内分泌癌的临床特征、预后因素和生存趋势:一项基于人群的研究。
Cancer Med. 2022 Dec;11(24):4935-4945. doi: 10.1002/cam4.4829. Epub 2022 May 21.
4
Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching Study.食管神经内分泌肿瘤的临床病理特征、预后及淋巴细胞浸润分析:一项基于手术的队列研究和倾向评分匹配研究
Cancers (Basel). 2023 Mar 13;15(6):1732. doi: 10.3390/cancers15061732.
5
[Clinical and prognostic features of the patients with esophageal squamous cell carcinomas as a first primary malignancy].[食管鳞状细胞癌作为首发原发性恶性肿瘤患者的临床及预后特征]
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2021 Jul;37(4):407-414. doi: 10.12047/j.cjap.6020.2021.008.
6
Clinicopathological features and prognosis of patients with esophageal cancer as the second primary cancer: a large population-based analysis using the SEER program [2000-2015].作为第二原发性癌症的食管癌患者的临床病理特征及预后:基于监测、流行病学与最终结果(SEER)计划[2000 - 2015年]的大型人群分析
Transl Cancer Res. 2020 Feb;9(2):1113-1124. doi: 10.21037/tcr.2019.12.64.
7
A new prognostic model of esophageal squamous cell carcinoma based on Cloud-least squares support vector machine.一种基于云最小二乘支持向量机的食管鳞状细胞癌新预后模型。
J Thorac Dis. 2023 Sep 28;15(9):4938-4948. doi: 10.21037/jtd-23-1058. Epub 2023 Sep 25.
8
Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population.食管神经内分泌癌人群的发病率、治疗及生存分析
Transl Cancer Res. 2020 Jul;9(7):4317-4329. doi: 10.21037/tcr-19-2650.
9
The prognostic performance of the log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma: A population study of the US SEER database and a Chinese single-institution cohort.食管鳞癌患者阳性淋巴结对数优势比的预后性能:美国 SEER 数据库的人群研究和中国单机构队列研究。
Cancer Med. 2021 Sep;10(17):6149-6164. doi: 10.1002/cam4.4120. Epub 2021 Jul 9.
10
A Comparative Analysis of the Gene Expression Profiles of Small Cell Esophageal Carcinoma, Small Cell Lung Cancer, and Esophageal Adeno/Squamous Carcinoma.小细胞食管癌、小细胞肺癌及食管腺癌/鳞癌基因表达谱的比较分析
Front Surg. 2021 Jul 30;8:655159. doi: 10.3389/fsurg.2021.655159. eCollection 2021.

引用本文的文献

1
Rare esophageal large-cell neuroendocrine carcinoma treated with Serplulimab: a case report.司铂利单抗治疗罕见食管大细胞神经内分泌癌:一例报告
Am J Transl Res. 2025 Apr 15;17(4):3247-3251. doi: 10.62347/TBQW3054. eCollection 2025.
2
Survival Analysis in Gastrointestinal Neuroendocrine Carcinoma With Bone Metastasis at Diagnosis.诊断时伴有骨转移的胃肠道神经内分泌癌的生存分析
Front Surg. 2022 Jan 28;9:820725. doi: 10.3389/fsurg.2022.820725. eCollection 2022.
3
Nomogram for the prediction of individualized overall survival of patients diagnosed with small cell esophageal carcinoma.用于预测小细胞食管癌患者个体化总生存期的列线图。
Ann Transl Med. 2021 Aug;9(16):1344. doi: 10.21037/atm-21-3900.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Esophageal Large-Cell Neuroendocrine Carcinoma with Inconsistent Response to Treatment in the Primary and Metastatic Lesions.食管大细胞神经内分泌癌,原发灶和转移灶对治疗反应不一致
Case Rep Gastroenterol. 2018 May 31;12(2):234-239. doi: 10.1159/000489295. eCollection 2018 May-Aug.
3
Progress in the treatment of esophageal neuroendocrine carcinoma.食管神经内分泌癌的治疗进展
Tumour Biol. 2017 Jun;39(6):1010428317711313. doi: 10.1177/1010428317711313.
4
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.基于列线图预测晚期食管胃腺癌患者一线化疗生存率:曲妥珠单抗时代的多中心前瞻性研究
Br J Cancer. 2017 Jun 6;116(12):1526-1535. doi: 10.1038/bjc.2017.122. Epub 2017 May 2.
5
Esophageal cancer: Risk factors, genetic association, and treatment.食管癌:危险因素、遗传关联和治疗。
Asian J Surg. 2018 May;41(3):210-215. doi: 10.1016/j.asjsur.2016.10.005. Epub 2016 Dec 13.
6
Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.有症状神经内分泌肿瘤综合征的治疗:最新进展与争议
Expert Opin Pharmacother. 2016 Nov;17(16):2191-2205. doi: 10.1080/14656566.2016.1236916. Epub 2016 Sep 23.
7
Large-Cell Neuroendocrine Carcinoma of the Esophagus: A Case from Saudi Arabia.食管大细胞神经内分泌癌:来自沙特阿拉伯的一例病例
Case Rep Gastroenterol. 2015 Oct 21;9(3):327-34. doi: 10.1159/000441381. eCollection 2015 Sep-Dec.
8
Management of small cell carcinoma of esophagus in China.中国食管小细胞癌的治疗管理。
J Gastrointest Surg. 2013 Jul;17(7):1181-7. doi: 10.1007/s11605-013-2204-7. Epub 2013 Apr 23.
9
Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases.食管原发性高级别神经内分泌癌:42 例切除标本的临床病理和免疫组织化学研究。
Am J Surg Pathol. 2013 Apr;37(4):467-83. doi: 10.1097/PAS.0b013e31826d2639.
10
Esophageal small-cell cancer: study of a rare disease.
Dis Esophagus. 2013 Sep-Oct;26(7):690-5. doi: 10.1111/dote.12022. Epub 2013 Jan 14.

2004年至2015年间食管大细胞神经内分泌癌的基于人群的分析。

Population-based analysis of esophageal large cell neuroendocrine carcinoma between 2004 and 2015.

作者信息

Yuan Guangda, Zhan Cheng, Zhu Donglin, Xie Hongya, Wei Tengteng, Lu Tao, Yang Yong, Zhu Yimeng, Wang Qun

机构信息

Department of Thoracic Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou 215001, China.

Department of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai 200032, China.

出版信息

J Thorac Dis. 2019 Dec;11(12):5480-5488. doi: 10.21037/jtd.2019.11.34.

DOI:10.21037/jtd.2019.11.34
PMID:32030267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6988077/
Abstract

BACKGROUND

Esophageal large cell neuroendocrine carcinoma (ELCNC) seems a rarely gastrointestinal malignancy. By far, its clinicopathological characteristics and prognosis have not been deeply studied.

METHODS

The data of patients having ELCNC was extracted from the Surveillance, Epidemiology, and End Results (SEER) database, then assessed and compared with information from patients with esophageal small cell neuroendocrine carcinoma (ESCNC) or esophageal squamous cell carcinoma (ESCC). We used univariate and multivariate analyses to accurately detect independent prognostic factors.

RESULTS

The data of 36 patients for ELCNC were obtained between 2004 and 2015. Compared with patients with ESCNC and ESCC, the mean survival time of ECLNC patients was worse than those with ESCC, while similar to ESCNC. Thus, ELCNC had significantly different clinicopathological characteristics compared to ESCNC and ESCC. Univariate and multivariate analyses revealed that age (P=0.001) and M stage (P=0.004) were independent prognostic factors.

CONCLUSIONS

ELCNC is a rare subtype of esophageal neuroendocrine carcinoma. The clinicopathological features differ from those of other esophageal carcinomas. Prognosis may be closely related to age and M stage.

摘要

背景

食管大细胞神经内分泌癌(ELCNC)似乎是一种罕见的胃肠道恶性肿瘤。迄今为止,其临床病理特征和预后尚未得到深入研究。

方法

从监测、流行病学和最终结果(SEER)数据库中提取患有ELCNC患者的数据,然后与食管小细胞神经内分泌癌(ESCNC)或食管鳞状细胞癌(ESCC)患者的信息进行评估和比较。我们使用单因素和多因素分析来准确检测独立的预后因素。

结果

2004年至2015年期间获得了36例ELCNC患者的数据。与ESCNC和ESCC患者相比,ECLNC患者的平均生存时间比ESCC患者差,但与ESCNC相似。因此,ELCNC与ESCNC和ESCC相比具有明显不同的临床病理特征。单因素和多因素分析显示,年龄(P=0.001)和M分期(P=0.004)是独立的预后因素。

结论

ELCNC是食管神经内分泌癌的一种罕见亚型。其临床病理特征与其他食管癌不同。预后可能与年龄和M分期密切相关。